First-In-Human Study to Assess the Pharmacokinetics and Safety of DS-6016a After Single Subcutaneous Injection in Healthy Japanese Adults.

Clin Pharmacol Drug Dev · 2026 · PMC12821564 · PMID 41562506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

7 Although no significant increase in serum iron was observed in the present study, an increasing trend was observed in the DS‐6016a group compared with the placebo group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.